Prof. Pachmann started her scientific career with the help of an Educational grant from the German Research Foundation (Deutsche Forschungsgemeinschaft) in 1974 at the Institute for Cell Research (Institutet för Cellforskning) Karolinska Institute Stockholm Sweden followed by a Research grant from the German Research Foundation (1976-1977) at the Institute for Hematology GSF (now Helmholtz Zentrum München). She was subsequently a Research Fellow at the Institute for Hematology GSF (now Helmholtz Zentrum München) from 1977 to 1982 followed by positions at the Klinikum rechts der Isar, Munich and Klinikum Innenstadt der Ludwig-Maximilians Universität, Munich. From 1996 to 1998 she was visiting scientist at the MD Anderson Cancer Center Houston Texas Section of Molecular Hematology and Therapy followed by 12 years as a Professor for Experimental Hematology and Oncology at the University of Jena.

Since 2012 she has been responsible for research at the Transfusion Center Bayreuth, Germany. Her key discoveries are the detection, quantitative determination and characterisation of tumour cells disseminated from solid tumours into the peripheral blood. The response of these cells to therapy correlates with clinical outcome and recently the possibility to clonally expand stem-like cells from these tumour cells circulating in the blood has been explored... More info

Prof. Alexander Haslberger leads working groups in Biotechnology, Microbiology and Genetics at the University of Vienna. His 120+ publications focus on bacteria in foods and the GI tract, probiotics, epigenetics, GMO foods and molecular epidemiology. Together with the University of Vienna, his laboratory has developed the diagnostic tool ‘Healthbiocare,’ which can test telomere length, epigenetic DNA markers, and disturbances and imbalances between major groups of bacteria that may cause immune, nervous system and metabolic disorders. Prof. Haslberger will pre-record a lecture that will be exclusively shown at the Genostics Cancer Seminar… more info

For some years Prof. Inui has researched and developed new immunotherapies such as GcMAF, Sonophotodynamic therapyand hyper T/NK cell therapy. In 2010 he began developing Second Generation High Dose GcMAF in collaboration with Tokushima University and soon established production of this for clinical use. In 2014 he instigated development and production of oral GcMAF. In collaboration with two universities he is developing several sonosensitizers and improving SDT protocol.

In 1987 he opened Inui Cancer Immunotherapy Clinic in Osaka. In 2010 he established Saisei Mirai Clinic in Kobe, closely followed by clinics in Tokyo and Osaka.

His collaborations with medical institutions in Japan and overseas continue, alongside his application of these new technologies in his clinics.

Dr. Kentaro Kubo will not be speaking at the seminar but will be available for questions. Please visit Saisei Mira Clinics seminar stand.

After obtaining a MSc in Fermentation Engineering (1995) and a PhD in Medicine - Regenerative Tissue Engineering (2004), Dr Kubo worked on developing an allogeneic cultured dermal substitute. A multi-center clinical study was performed on this product at 30 hospitals across Japan (the Regenerating Medical Millennium Project of the Ministry of Health, Labor and Welfare, 1999-2004).Since 2008, as Director of Cell Processing Center in Saisei Mirai Clinics, Dr Kubo has overseen the development of the latest most effective treatments such as GcMAF and Hyper T/NK cells for patients suffering from cancer.

Dr Stefan Schuster started at SIMFO in 2013 as assistant to the board and gained a lot of experience in molecular diagnostics. Since 2015 he joined the board of management of SIMFO GmbH. He is responsible for scientific collaborations and economic partnerships worldwide, i.e. DKFZ, Heidelberg Germany, training of physicians as well as the further development of the maintrac method. In 2015 he successfully initiated collaboration together with the University of Bayreuth funded by the German Ministry for economics. Also in 2015 he was accountable for several EU funded H2020 projects. During the past years he developed the product strategy of SIMFO/maintrac. 2013 he was awarded as one of the best seven business plans of the Bavarian State Government (BPWN competition). In the past years he attended several congresses and held successfully lectures and published articles about circulating tumor cells. From 2009 to 2013 he worked as research associate at the University of Erlangen at the Institute of Medicinal Chemistry. He developed assay systems to study the influence of functional selective ligands. He laid there his foundation to work in the field of molecular biology. In 2008 he was an intern at Novartis Pharma GmbH and gained first experiences in the field of marketing and clinical development. He studied pharmacy at the University of Erlangen, Germany, from 2003 to 2007.

Dr. Mark Donohoe is one of Australia’s most experienced and best known medical practitioners in the fields of Nutritional and Environmental Medicine. He has a long history working in the emerging field of “integrative medicine”, and continues to bring orthodox & complementary medicine together in his Cremorne medical practice..

The underlying philosophy of Dr Donohoe’s practice is that knowledge and understanding provide people with the ability to manage their own health, and even to heal themselves.

Understanding the contribution of stress, nutrition, the work and home environment and genetics to health and illness provides the best opportunities to make specific and profound changes often required to return to health.

Dr Donohoe’s experience and knowledge of complex medical conditions, and his use of orthodox & complementary modalities and management options approach to identifying and managing chronic illness…more info

Dr Joachim Fluhrer is a medical practitioner who is widely regarded as a leader in the field of integrative and personalised medicine.

His particular interest is personalised cancer management and the early adoption into clinical practice of evidence-based liquid biopsy and tumour profiling. He currently incorporates liquid biopsy into his own practice, sourcing the most advanced, sensitive, specific and clinically validated technology internationally and advocating for the technique through national and online seminars and practitioner education.

Dr Fluhrer is considered one of Australia’s most experienced practitioners and educators in combining nutritional and environmental medicine with standard medical practice. As a senior lecturer, he has presented at seminars and conferences nationally and internationally for more than 30 years.

His positions include member of the Cancer Research Network, Sydney University, Faculty Member of the Australasian College for Medical Nutrition, board member of the Australasian Integrative Medical Association, Vice-President of the Australian College for Nutritional andEnvironmental Medicine (1999-2007) and committee member of the Australian Pharmaceutical Advisory Council (2003-2004). More info.

Dr. Soraya Felix

Dr. Soraya Felix MD, AustraliaMasterderm clinic

In her former years Dr Soraya Felix had a colourful background in her home country Brazil, spanning from scientific research right through to supervising high-level government projects which until this very day, much of her work still forms part of the foundational structure in various fields of science in Brazil.

Dr Soraya Felix first completed a double undergraduate degree in Biology and Chemistry. She went on to complete an additional seven years of research to acquire an honours degree in Molecular Biology, under the very strict supervision of Professor Fernando Ubatuba who is most renowned for his Nobel winning prize contribution in the discovery of Prostacyclin. This discovery was instrumental for the development of Aspirin in later years. After her honours degree she went on to complete a Masters in Pharmacology and a double undergraduate in Medicine and Surgery.

Dr Soraya Felix later contributed to research work for the World Health Organisation, in recognition of her work she was endorsed to become an expert advisor to the Brazilian national regulatory body governing Pharmaceuticals. During this period Dr Soraya Felix was then appointed to a senior role in the government as the advisor to the Brazilian Minister of Health. As the prime advisor she was responsible for supervising several projects of national interest. During this time she worked close hand with Professor Sergio Ferreira who contributed to the discovery of the first active peptide Bradykinin, this also paved the way for the first ace inhibiter. Professor Ferreira and Dr Soraya Felix collaborated on many successful projects together.

After completing her tenure in office, Dr Soraya Felix migrated to Australia, with consideration of the academic calibre of both Universities and supervisors she was immediately awarded complete recognition for her former degrees in Australia. Even though she had full recognition, Dr Soraya Felix decided to repeat the double undergraduate degree of Medicine and Surgery at the Flinders University of South Australia.

After her graduation she went on to complete a further three years of specialist training at the Queen Elizabeth Hospital in Adelaide, she then completed her Fellowship with the Royal College of General Practice. Dr Soraya Felix has since completed an additional 11 years of extensive formal training and rigorous examinations in various fields.

Dr Soraya Felix is committed to the education of future Physicians, she taught for many years in a training program provided for overseas doctors to obtain their Australian medical qualifications, held at the Queen Elizabeth Hospital, Adelaide. She was also a co-joint lecturer at the Medical School of The Newcastle University, NSW.

Michael Thomsen is master herbalist and naturopath with over 30 years experience. Originally from Denmark, he completed studies in Naturopathy and Herbal Medicine in Sydney, graduating in 1986.

He has a Master of Science, Graduate School of Integrative Medicine, Swinburne University and is currently a PhD scholar at Sydney University Medical School. Michael is researching radiochemotherapy-induced mucositis, intestinal dysbiosis and the role of probiotics in preventing and or reducing chemotherapy/radiotherapy-induced diarrhoea in patients diagnosed with abdominal or pelvic tumours.

Michael has extensive industry experience as past technical manager of leading herbal medicine companies in Australia.

He is the original author of the popular Phytotherapy Desk Reference now in its fourth edition having sold 10,000 copies worldwide.

MEDICAL ADVICE DISCLAIMER: By visiting the Genostics website, you have agreed that you accept the Medical Advice Disclaimer here stated and are willing to visit the Genostics website. The information on any page in the Genostics website, together with all information within any written, audio, downloadable material and other media, as well as information on external links provided on the Genostics website, as well as information on any printed or digital material distributed by Genostics is for education purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her Health Practitioner to determine the appropriateness of the information for their own situation or if they have any questions regarding a medical condition or treatment plan. Reading the information within this webpage does not create a Health Practitioner - Patient relationship. Genostics does not offer any medical advice. Genostics does not engage in medical practice. Do not use this information to disregard any medical advice, nor to delay seeking medical advice because of something you have read or seen within this website. No warranty is given as to the accuracy of information contained or connected to this website, and persons who rely on it do so at their own risk.

IMAGES, LINKS & COPYRIGHT: Some images on the Genostics website and printed material are public domain. For these images, the source has been credited as a watermark on the bottom left hand corner of the image. All other images including logos are copyright Genostics and are not available for reuse. All text on the Genostics website, digitial and printed material is copyright Genostics and not available for reuse. Use of images on the Genostics website and printed material does not imply any relationship between Genostics and the image source, nor does it imply any endorsement of Genostics by the image source and vice versa. The presence of external links provided on the Genostics website, digital and printed media does not imply any relationship between Genostics and the company owning the domain that has been linked, nor does it imply any endorsement of Genostics by the company owning the linked domain and vice versa.